市場調查報告書
商品編碼
1211007
全球脂質納米顆粒市場規模研究和預測:按類型(固體脂質納米顆粒(SLN)、納米結構脂質載體(NLC)、其他)、應用、最終用戶、地區2022-2029Global Lipid Nanoparticles Market Size study & Forecast, by Type (Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, Others) by Application, by End User and Regional Analysis, 2022-2029 |
2021 年全球脂質納米顆粒市場價值約為 6.875 億美元,預計在 2022-2029 年預測期內將以超過 13.6% 的健康增長率增長。
脂質納米粒子是一種由脂質組成的納米粒子。 它是一種用於遞送核酸的新型藥物製劑和新型藥物遞送系統,用於治療癌症等疾病。 再加上 mRNA 疫苗製造商對脂質系統的需求激增、納米粒子在基因治療中越來越多地被用作載體,以及越來越多的製藥和生物技術公司是決定全球市場需求的主要因素。
對創新和個性化醫療的日益重視,尤其是將藥物輸送到目標部位,是市場需求的主要驅動力。 根據 Statista 的數據,2019 年全球個性化醫療市場價值約為 1.98 萬億美元,預計到 2022 年將增長至 2.77 萬億美元。 因此,對個性化醫療日益增長的偏好正在推動脂質納米顆粒作為腫瘤學和神經學相關藥物遞送的載體,加速市場增長。 此外,在預測期內,研發活動投資的增加以及市場參與者開發獨特產品的積極性不斷提高,帶來了各種有利可圖的機會。 然而,嚴格法規的實施和與使用脂質納米顆粒相關的一些副作用阻礙了整個 2022-2029 年預測期內的市場增長。
考慮進行脂質納米顆粒全球市場研究的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於對產品批准的更多關注和主要參與者的強大存在,北美在收入方面佔據了市場主導地位。 另一方面,由於人口增長、生活方式的快速變化以及對膳食補充劑的需求不斷增長等因素,預計亞太地區在預測期內將以最高的複合年增長率增長。
這項研究的目的是定義近年來各個細分市場和國家的市場規模,並預測他們在未來幾年的價值。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。
它還提供了關鍵方面的詳細信息,例如決定市場未來增長的驅動因素和挑戰。 此外,它還包含供利益相關者投資的微觀市場潛在機會,以及對主要參與者的競爭格局和產品供應的深入分析。
Global Lipid Nanoparticles Market is valued at approximately USD 687.5 million in 2021 and is anticipated to grow with a healthy growth rate of more than 13.6% over the forecast period 2022-2029. Lipid nanoparticles are a type of a nanoparticle that is composed of lipids. It is a novel pharmaceutical formulation and new pharmaceutical drug delivery system that are used are used to carry nucleic acids in the treatment of diseases such as cancer. The surging demand for lipid systems from mRNA vaccine manufacturers, rising adoption of nanoparticles in gene therapy as vector, coupled with the increasing number of pharmaceutical & biotechnology companies are the primary factors that are stipulating the market demand across the globe.
The rising emphasis on innovative and personalized medicine to deliver drugs at specifically targeted sites is a chief driving factor for the market demand. According to Statista, the global market for personalized medicine was worth approximately USD 1,980 billion in 2019 and is expected to increase to USD 2,770 billion by the year 2022. Consequentially, the increasing preference towards personalized medicines is fueling the adoption of lipid nanoparticles as a carrier in delivering oncology and neurology-related drugs, which is accelerating market growth. Moreover, the rising investment on R&D activities, as well as the increasing initiatives by market players for the development of distinct products are presenting various lucrative opportunities over the forecasting years. However, the imposition of stringent regulations and several side effects associated with the use of lipid nanoparticles are hindering the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Lipid Nanoparticles Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing focus on receiving product approvals and the robust presence of the major players. Whereas, the Asia Pacific is also expected to grow with the highest CAGR during the forecast period, owing to factors such as rising populations, rapidly changing lifestyles, and rising demand for nutraceutical therapies in the market space.
Major market players included in this report are:
Merck KGaA
Evonik Industries AG
Gattefosse
Precision NanoSystems
ABITEC Corporation
Nippon Oil & Fats Corporation
Lipoid GmbH
BASF SE
Dishman Group
IOI Oleo GmbH
Recent Developments in the Market:
Global Lipid Nanoparticles Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Type, Application, End User, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Solid Lipid Nanoparticles (SLNs)
Nanostructured Lipid Carriers (NLCs)
Others
By Application:
Therapeutics
Research
By End User:
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable